Sterile Single-use Gastroscope Market Size, Share, Growth, and Industry Analysis, By Type (GERD, Chronic Gastritis, Gastric Ulcers, Others), By Application (Hospitals, Ambulatory Surgical Centers), Regional Insights and Forecast to 2035

Sterile Single-use Gastroscope Market Overview

The global sterile single-use gastroscope market size is valued at USD 107.76 million in 2026 and is projected to reach USD 564.17 million by 2035, expanding at a CAGR of 20.19%. Sterile single-use gastroscopes are gaining adoption as healthcare providers prioritize infection prevention, immediate device availability, predictable performance, simplified clinical workflows, and reduced dependence on complex endoscope reprocessing. Growing gastrointestinal diagnostic volumes and expanding use of portable endoscopy systems further strengthen demand.

The United States represents an important market for sterile single-use gastroscopes because of its large gastrointestinal procedure base, advanced hospital infrastructure, and growing emphasis on infection prevention. Approximately 7.25 million upper endoscopies are performed annually in the country, creating a substantial addressable procedure pool. Sterile single-use gastroscopes are particularly relevant for intensive care units, operating rooms, emergency procedures, and immunocompromised patients. FDA-cleared systems support diagnostic and therapeutic upper gastrointestinal examinations, while portable processing platforms allow procedures to move beyond conventional endoscopy suites and into bedside clinical environments.

Key Findings

• Market Size and Forecast: The sterile single-use gastroscope market reaches USD 107.76 million in 2026 and USD 564.17 million by 2035, recording 20.19% CAGR.
• Type Leadership: GERD accounts for an estimated 39% share, supported by frequent diagnostic endoscopy requirements and growing evaluation of persistent reflux symptoms.
• Application Leadership: Hospitals hold approximately 68% share as emergency endoscopy, inpatient diagnostics, operating-room procedures, bleeding management, and critical-care applications support adoption.
• Key Company Landscape: Ambu and EvoEndo strengthen single-use gastroscopy through sterile endoscope platforms, portable visualization systems, clinical development, and expanding regulatory clearances.
• Fastest Growing Region: North America holds approximately 39% share, supported by advanced endoscopy infrastructure, infection-control awareness, regulatory approvals, and substantial procedure volumes.
• Key Trends: Therapeutic capability is expanding as 4.2 mm working channels and approximately 90% higher suction performance improve single-use gastroscope functionality.

Latest Trends

Clinical adoption of sterile single-use gastroscopes is increasingly moving beyond routine diagnostic visualization toward therapeutic and bedside procedures. Manufacturers are improving image quality, maneuverability, suction capability, working-channel dimensions, and portability to make disposable systems practical for upper gastrointestinal bleeding, foreign-body removal, stricture management, intraoperative endoscopy, and intensive care procedures. Advanced therapeutic models incorporate a 4.2 mm working channel, enabling greater accessory compatibility and stronger suction capability than narrower therapeutic designs. Portable display units also reduce dependence on fixed endoscopy towers, allowing clinicians to bring gastroscopy capabilities directly to operating rooms, emergency departments, and critical-care environments.

Infection prevention remains another defining sterile single-use gastroscope market trend. Every disposable gastroscope arrives sterile and is discarded after the procedure, eliminating patient-to-patient contamination risks associated with inadequate reprocessing. A systematic clinical evidence base involving 965,960 patients has increased industry attention toward comparative performance, infection risk, and diagnostic effectiveness across disposable and reusable endoscopy technologies. Workflow efficiency is also becoming an important purchasing consideration because single-use devices eliminate extensive cleaning, drying, storage, transportation, repair, and reprocessing activities. Sustainability remains a challenge, encouraging manufacturers to investigate bio-attributed plastics, optimized packaging, material reduction, and more efficient waste-management strategies.

Market Dynamics

DRIVER

"Growing emphasis on infection prevention and immediate gastroscope availability"

Infection-control requirements are a major driver of sterile single-use gastroscope market growth because flexible gastrointestinal endoscopes have intricate channels and internal surfaces requiring rigorous decontamination between procedures. Single-use systems arrive sterile and are discarded after one patient, eliminating the reprocessing stage and providing predictable device availability. Published evidence has estimated infection risks associated with contaminated reusable gastrointestinal endoscopes at up to 0.8% under evaluated conditions, although reported risk varies considerably by device and clinical environment. Hospitals are therefore evaluating disposable gastroscopes for vulnerable patients, emergency procedures, critical-care settings, isolation cases, and situations where immediate access to a sterile scope can improve operational responsiveness.

RESTRAINT

"Established reusable endoscopy infrastructure limits complete replacement"

Reusable gastroscopes remain deeply embedded within high-volume gastrointestinal departments, limiting immediate conversion toward disposable alternatives. Large hospitals have established endoscopy towers, reprocessing equipment, trained technicians, maintenance programs, inventory systems, and clinical protocols centered on reusable devices. For departments performing substantial daily procedure volumes, existing capital infrastructure can make reusable systems operationally attractive when utilization is high. Clinical evidence also indicates that single-use gastrointestinal endoscopes can demonstrate similar or slightly reduced technical performance compared with established reusable alternatives depending on procedure complexity. Procurement committees must therefore evaluate infection-control benefits, waste generation, procedure mix, device capability, supply reliability, and total operational requirements before expanding disposable gastroscope adoption across an entire department.

OPPORTUNITY

"Expansion of portable endoscopy into critical-care and operating-room environments"

Portable gastroscopy creates substantial opportunities for sterile single-use gastroscope manufacturers because gastrointestinal visualization increasingly occurs outside conventional endoscopy suites. Compact processing units and individually packaged sterile scopes can support bedside procedures in intensive care, operating rooms, emergency departments, satellite facilities, and ambulatory environments. The United States performs more than 7 million upper endoscopy procedures annually, illustrating the substantial clinical base from which specialized disposable applications can develop. Manufacturers can target upper gastrointestinal bleeding, intraoperative assessment, high-risk infection cases, emergency foreign-body removal, and immunocompromised patients. Expanding therapeutic capability through larger working channels, improved suction, enhanced imaging, better tip articulation, and accessory compatibility can further increase the addressable procedure population.

CHALLENGE

"Balancing clinical performance with environmental and procurement requirements"

Waste generation represents an important challenge for the sterile single-use gastroscope market because every completed procedure creates a discarded endoscope containing polymers, electronics, optical components, wiring, and packaging materials. Endoscopy is already considered a resource-intensive medical specialty, increasing scrutiny of disposable device adoption among healthcare organizations pursuing sustainability objectives. Manufacturers must reduce material intensity without compromising sterility, durability, image quality, articulation, suction, or working-channel performance. Clinical teams also expect disposable gastroscopes to reproduce familiar handling characteristics while remaining economically practical. Product developers are responding with bio-attributed plastics, lighter components, compact processing equipment, packaging optimization, recycling initiatives, and manufacturing improvements intended to balance infection prevention with environmental responsibility.

Sterile Single-use Gastroscope Market Segmentation

The sterile single-use gastroscope market is segmented by type and application to assess differences in clinical indication, procedure setting, diagnostic requirements, workflow patterns, and purchasing behavior. By type, the market includes GERD, chronic gastritis, gastric ulcers, and other gastrointestinal indications requiring visualization of the esophagus, stomach, or proximal duodenum. By application, the market is divided between hospitals and ambulatory surgical centers. Hospitals represent the principal environment for emergency, inpatient, surgical, and critical-care endoscopy, while ambulatory surgical centers provide an expanding setting for scheduled gastrointestinal examinations. Single-use technology supports both segments through sterile availability and simplified equipment management.

By Type

Based on type the global market can be categorized into GERD, Chronic Gastritis, Gastric Ulcers, Others.

• GERD: GERD represents an estimated 39% share of the sterile single-use gastroscope market by clinical indication. Gastroscopy is important for patients requiring evaluation of persistent reflux symptoms, suspected esophagitis, strictures, Barrett's esophagus, bleeding, or other complications requiring direct visualization. Sterile single-use gastroscopes can support examinations in conventional endoscopy units as well as bedside and operating-room settings. Immediate device availability is useful where diagnostic evaluation cannot be delayed by reusable scope availability or reprocessing schedules. Improved imaging, lightweight handling, accessory compatibility, and compact processing systems are supporting wider use for upper gastrointestinal examinations associated with reflux-related disease.
• Chronic Gastritis: Chronic gastritis accounts for an estimated 25% share of sterile single-use gastroscope demand by type. Endoscopic examination helps clinicians evaluate persistent inflammation, mucosal abnormalities, erosions, bleeding, suspicious lesions, and changes requiring tissue sampling. Single-use gastroscopes provide a sterile device for each examination and can reduce workflow dependence on cleaning and disinfection infrastructure. This characteristic is particularly relevant for hospitals managing patients with infection-control considerations or facilities requiring additional gastroscopy capacity without expanding reprocessing departments. Continued improvements in visualization, distal-tip design, water delivery, working-channel access, and maneuverability support disposable gastroscope use for diagnostic assessment and targeted biopsy procedures.
• Gastric Ulcers: Gastric ulcers hold an estimated 21% share of the sterile single-use gastroscope market by type. Gastroscopy allows direct assessment of ulcer characteristics, bleeding sites, surrounding tissue, and abnormalities requiring biopsy or endoscopic intervention. Disposable gastroscopes are increasingly relevant for urgent upper gastrointestinal bleeding assessments where rapid device availability and strong suction capability are clinically useful. Therapeutic single-use designs provide larger working channels that support aspiration and compatibility with endotherapy accessories. Their sterile condition also removes the delay associated with post-procedure decontamination. Hospitals can therefore maintain individually packaged scopes for emergency cases, intensive-care procedures, and operating-room examinations where rapid deployment supports clinical workflow.
• Others: Other indications account for an estimated 15% share and include strictures, foreign bodies, unexplained upper gastrointestinal symptoms, selected bleeding conditions, postoperative assessment, feeding-related procedures, and specialized diagnostic examinations. This segment benefits particularly from the flexibility of portable single-use gastroscopy because procedures can occur outside dedicated gastrointestinal suites. Sterile availability supports isolated patients and situations where reusable equipment is unavailable, quarantined, undergoing repair, or committed to another procedure. Manufacturers are expanding therapeutic functionality to address more complicated cases through improved suction, wider working channels, enhanced articulation, auxiliary water delivery, accessory compatibility, and imaging capabilities designed to broaden the clinical usefulness of disposable gastroscopes.

By Application

Based on application the global market can be categorized into Hospitals, Ambulatory Surgical Centers.

• Hospitals: Hospitals account for an estimated 68% share of sterile single-use gastroscope demand. Their leadership reflects substantial gastrointestinal procedure volumes and the need to support scheduled examinations, emergency interventions, critical-care procedures, operating-room cases, and upper gastrointestinal bleeding management. Single-use gastroscopes provide immediate sterile availability without requiring the cleaning, drying, transport, storage, and maintenance workflow associated with reusable devices. Hospitals can also position portable visualization systems across departments rather than concentrating all procedures inside centralized endoscopy suites. Adoption is strongest where infection prevention, unpredictable emergency demand, vulnerable patient populations, or limited access to reusable equipment creates operational value for disposable endoscopy.
• Ambulatory Surgical Centers: Ambulatory surgical centers represent an estimated 32% share of the sterile single-use gastroscope market. These facilities emphasize efficient patient turnover, standardized procedure workflows, predictable scheduling, and careful management of capital equipment. Disposable gastroscopes can reduce requirements for specialized reprocessing infrastructure while giving clinicians a sterile instrument for each patient. The approach can be particularly relevant for smaller centers establishing gastrointestinal capabilities or expanding procedure capacity without adding extensive decontamination systems. Portable processors, simplified setup, consistent device condition, and reduced repair exposure strengthen adoption potential. Continued improvement in therapeutic capability can allow ambulatory centers to address a broader selection of diagnostic and interventional upper gastrointestinal procedures.

Sterile Single-use Gastroscope Market Regional Outlook

• North America

North America accounts for an estimated 39% share of the sterile single-use gastroscope market. The region benefits from sophisticated hospital infrastructure, substantial endoscopy volumes, strong infection-control awareness, and early adoption of disposable endoscopic technologies. The United States forms the principal demand center, supported by approximately 7.25 million upper endoscopy procedures annually. Large hospital systems increasingly evaluate disposable gastroscopes for emergency procedures, critical-care environments, operating rooms, and patients with elevated infection concerns.

Regional demand is also supported by established regulatory pathways for gastrointestinal endoscopy devices and growing availability of clinically capable single-use platforms. Hospitals can deploy compact visualization systems without relying exclusively on fixed endoscopy towers. Ambulatory surgical centers provide another expansion pathway because disposable scopes can simplify equipment management. Product development increasingly focuses on stronger suction, larger working channels, improved imaging, ergonomic handling, and expanded indications, strengthening the role of single-use gastroscopy across specialized clinical environments.

• Europe

Europe represents an estimated 24% share of global sterile single-use gastroscope demand. The regional market is supported by established gastrointestinal services, strict infection-prevention protocols, growing evaluation of sustainable medical technology, and increasing interest in disposable endoscopy for selected high-risk procedures. Germany, the United Kingdom, France, Italy, and Nordic healthcare systems provide important adoption environments. Hospitals increasingly assess single-use devices according to clinical effectiveness, workflow efficiency, environmental impact, procurement requirements, and compatibility with existing endotherapy accessories.

European demand also reflects growing interest in reducing the operational complexity associated with reusable endoscope reprocessing. Disposable gastroscopes can provide predictable availability for emergency procedures and decentralized endoscopy while eliminating repeated disinfection cycles. Sustainability expectations remain particularly influential, encouraging development of bio-attributed plastics and lower-impact packaging. Manufacturers able to demonstrate clinical performance, responsible material selection, efficient disposal strategies, and dependable distribution are positioned to strengthen adoption among hospitals seeking to balance infection prevention with environmental objectives.

• Asia Pacific

Asia Pacific accounts for an estimated 26% share of the sterile single-use gastroscope market. Expanding healthcare infrastructure, increasing gastrointestinal disease detection, growing endoscopy capacity, and investment in minimally invasive diagnostics support regional adoption. China, Japan, South Korea, India, and Australia represent significant healthcare markets with expanding gastrointestinal procedure requirements. Disposable gastroscopy is particularly relevant for facilities seeking additional procedure capacity without constructing extensive reprocessing infrastructure or maintaining large inventories of reusable endoscopes.

Regional medical-device manufacturing capabilities also create opportunities for cost optimization and local development of disposable endoscopy platforms. Large patient populations increase demand for scalable diagnostic systems, while private hospitals and specialty centers continue investing in advanced visualization technology. Adoption nevertheless varies because procurement budgets, reimbursement systems, regulatory pathways, and clinician preferences differ significantly between countries. Suppliers emphasizing affordable devices, portable processing systems, reliable distribution, image quality, and clinical training can address underserved hospitals and expanding ambulatory gastrointestinal services.

• Middle East & Africa

Middle East & Africa holds an estimated 6% share of the sterile single-use gastroscope market. Demand is concentrated in advanced hospital systems across Gulf countries and selected private healthcare networks in Africa. Healthcare modernization, specialist hospital development, medical tourism, and investment in infection-control technologies support adoption. Disposable gastroscopes can provide particular value for facilities where endoscope reprocessing capacity is limited or where maintaining sufficient reusable inventory creates operational challenges.

The region also presents opportunities for portable endoscopy systems that can extend gastrointestinal diagnostic capabilities beyond major tertiary hospitals. Sterile individually packaged devices simplify deployment in smaller facilities and specialized clinical environments. Adoption remains constrained by procurement budgets, import dependence, uneven reimbursement, and limited specialist availability in several countries. International manufacturers working with regional distributors, clinical training organizations, and hospital groups can strengthen market access while demonstrating workflow advantages and dependable product availability.

• Rest of the World

Rest of the World represents an estimated 5% share of sterile single-use gastroscope demand. Latin America forms an important component, with Brazil and Mexico providing significant gastrointestinal procedure volumes and established private hospital networks. Disposable gastroscopes offer opportunities where facilities seek portable diagnostic capacity, reduced dependence on centralized reprocessing, and sterile equipment availability for selected patient populations. Private healthcare investment can support gradual adoption in larger metropolitan medical centers.

Market expansion depends on product affordability, regulatory registration, distributor capabilities, physician training, and access to compatible endotherapy equipment. Smaller hospitals may benefit from single-use technology because purchasing a portable processor can require less infrastructure than establishing comprehensive reusable endoscope cleaning operations. Suppliers capable of providing clinical education, dependable inventory, technical support, and flexible procurement arrangements can expand penetration. Local partnerships will remain important for navigating diverse regulatory and hospital purchasing systems.

KEY INDUSTRY PLAYERS

The sterile single-use gastroscope market remains concentrated around specialist single-use endoscopy developers, with Ambu maintaining a prominent commercial position through its aScope Gastro platform and therapeutic aScope Gastro Large. EvoEndo provides additional competition through a sterile single-use system designed for upper gastrointestinal visualization and treatment. Fujifilm is also advancing single-use upper gastrointestinal endoscopy technology, increasing competitive pressure around visualization and processor performance. Competitive strategies focus on regulatory expansion, therapeutic functionality, larger working channels, portable visualization, improved suction, clinical evidence, physician training, hospital partnerships, and broader procedure coverage. Emerging participants are expected to intensify competition as regulatory clearances expand.

List of Top Sterile Single-use Gastroscope Companies

• Ambu

List of Top 2 Companies Market Share

• Ambu holds an estimated 68% share, supported by established sterile gastroscope platforms and international commercialization.

Investment Analysis and Opportunities

Investment opportunities in the sterile single-use gastroscope market are concentrated in imaging technology, portable processing platforms, therapeutic functionality, manufacturing automation, materials engineering, and clinical evidence generation. Investors can target technologies that expand disposable gastroscopy from basic visualization into procedures requiring suction, biopsy, bleeding management, foreign-body retrieval, and advanced endotherapy. A 4.2 mm therapeutic working channel demonstrates how product engineering can expand the clinical scope of single-use devices. Additional opportunities exist in miniaturized electronics, improved sensors, light-emitting components, image-processing software, ergonomic control systems, water delivery, and accessory compatibility. Manufacturers with scalable automated production can improve consistency while supporting expanding procedure demand.

Healthcare decentralization creates another investment opportunity because portable single-use gastroscopy can extend gastrointestinal visualization beyond dedicated endoscopy departments. Compact systems can support intensive care, operating rooms, emergency units, ambulatory centers, satellite hospitals, and specialist clinics. Approximately 68% of current demand is concentrated in hospitals, leaving meaningful expansion potential across outpatient settings as technology becomes more capable. Investors can also support sustainable material innovation, recycling programs, bio-attributed plastics, optimized packaging, and lower-material device architectures. Strategic partnerships with hospitals, gastroenterologists, distributors, endotherapy accessory manufacturers, and clinical research organizations can accelerate adoption while producing evidence demonstrating procedural performance and workflow value.

New Product Development

New product development in the sterile single-use gastroscope market focuses on therapeutic capability, image quality, suction, maneuverability, portability, and sustainability. Advanced disposable gastroscopes now incorporate working channels measuring 4.2 mm, enabling stronger aspiration and broader accessory compatibility for demanding procedures. Selected therapeutic systems deliver approximately 90% higher suction flow than conventional 3.7 mm channel designs under comparable evaluation conditions. Manufacturers are also improving distal-tip articulation, field visualization, water delivery, lightweight connectors, and digital processing. Future development will increasingly emphasize high-definition imaging, intelligent image enhancement, compact processors, bio-attributed polymers, reduced packaging, procedure-specific configurations, and integration with digital endoscopy documentation systems.

Recent Developments

• September 2026: Ambu secured FDA clearance for expanded indications covering its aScope Gastro and Gastro Large systems, extending single-use gastrointestinal endoscopy into flexible sigmoidoscopy and broadening procedural reach across bedside, operating-room, upper-GI and lower-GI applications.

Report Coverage

The sterile single-use gastroscope market report evaluates technology development, clinical adoption, end-user demand, regional positioning, competitive activity, investment priorities, and product innovation. Type analysis covers GERD, chronic gastritis, gastric ulcers, and other upper gastrointestinal indications, while application analysis examines hospitals and ambulatory surgical centers. Hospitals account for an estimated 68% share, reflecting emergency, inpatient, critical-care, surgical, and diagnostic gastroscopy requirements. Regional coverage includes North America, Europe, Asia Pacific, Middle East & Africa, and Rest of the World. The competitive assessment examines Ambu and emerging sterile gastroscopy participants alongside relevant endoscopy technology developers. Coverage also evaluates infection prevention, reusable scope substitution, portability, therapeutic capability, working-channel innovation, sustainability, regulatory activity, clinical workflow, procurement considerations, and opportunities for decentralized gastrointestinal endoscopy.